Healios K.K. (OTCMKTS:HLOSF – Get Free Report)’s share price fell 7.5% during mid-day trading on Wednesday . The company traded as low as 1.60 and last traded at 1.60. 900 shares were traded during trading, a decline of 41% from the average session volume of 1,523 shares. The stock had previously closed at 1.73.
Healios K.K. Stock Down 7.5 %
The firm’s fifty day simple moving average is 1.51 and its 200 day simple moving average is 1.21.
About Healios K.K.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
Further Reading
- Five stocks we like better than Healios K.K.
- What is a SEC Filing?
- 3 Momentum Trades for October With Ample Upside Ahead
- What are earnings reports?
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- Profitably Trade Stocks at 52-Week Highs
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.